BR9712058B1 - formulações para uso de ivermectina, processo para sua preparação e uso. - Google Patents

formulações para uso de ivermectina, processo para sua preparação e uso.

Info

Publication number
BR9712058B1
BR9712058B1 BRPI9712058-8A BR9712058A BR9712058B1 BR 9712058 B1 BR9712058 B1 BR 9712058B1 BR 9712058 A BR9712058 A BR 9712058A BR 9712058 B1 BR9712058 B1 BR 9712058B1
Authority
BR
Brazil
Prior art keywords
ivermectin
formulations
preparation
Prior art date
Application number
BRPI9712058-8A
Other languages
English (en)
Other versions
BR9712058A (pt
Inventor
Michael Dr Grosse-Bley
Richard Dr Kujanek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BRPI9715298A priority Critical patent/BRPI9715298B8/pt
Publication of BR9712058A publication Critical patent/BR9712058A/pt
Publication of BR9712058B1 publication Critical patent/BR9712058B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
BRPI9712058-8A 1996-09-18 1997-09-08 formulações para uso de ivermectina, processo para sua preparação e uso. BR9712058B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI9715298A BRPI9715298B8 (pt) 1996-09-18 1997-09-08 formulações para injeção de avermectinas ou milbemicinas para uso veterinário, processo para sua preparação e uso

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19638045A DE19638045A1 (de) 1996-09-18 1996-09-18 Injektionsformulierungen von Avermectinen und Milbemycinen
PCT/EP1997/004867 WO1998011902A1 (de) 1996-09-18 1997-09-08 Injektionsformulierungen von avermectinen und milbemycinen

Publications (2)

Publication Number Publication Date
BR9712058A BR9712058A (pt) 1999-08-24
BR9712058B1 true BR9712058B1 (pt) 2009-05-05

Family

ID=7806009

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9715298A BRPI9715298B8 (pt) 1996-09-18 1997-09-08 formulações para injeção de avermectinas ou milbemicinas para uso veterinário, processo para sua preparação e uso
BRPI9712058-8A BR9712058B1 (pt) 1996-09-18 1997-09-08 formulações para uso de ivermectina, processo para sua preparação e uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI9715298A BRPI9715298B8 (pt) 1996-09-18 1997-09-08 formulações para injeção de avermectinas ou milbemicinas para uso veterinário, processo para sua preparação e uso

Country Status (18)

Country Link
US (1) US6617314B2 (pt)
EP (1) EP0939638B1 (pt)
JP (1) JP4822196B2 (pt)
KR (1) KR20000035978A (pt)
CN (1) CN1130203C (pt)
AR (1) AR008844A1 (pt)
AT (1) ATE228845T1 (pt)
AU (1) AU750874B2 (pt)
BR (2) BRPI9715298B8 (pt)
CA (1) CA2265952C (pt)
DE (2) DE19638045A1 (pt)
DK (1) DK0939638T3 (pt)
ES (1) ES2184135T3 (pt)
HK (1) HK1022845A1 (pt)
NZ (1) NZ334673A (pt)
PL (1) PL332137A1 (pt)
WO (1) WO1998011902A1 (pt)
ZA (1) ZA978352B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) * 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
AU781682B2 (en) 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US6872708B2 (en) * 2001-09-10 2005-03-29 Mitsukazu Matsumoto Local injection prescription
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
CN102316876B (zh) * 2009-02-16 2013-07-17 佐蒂斯有限责任公司 高剂量多拉菌素制剂
CN101773467B (zh) * 2010-01-20 2015-09-09 北京大北农动物保健科技有限责任公司 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法
CN103096934A (zh) * 2010-03-09 2013-05-08 詹森生物科技公司 非水性高浓度低粘度混悬剂
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) * 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
KR20140136005A (ko) 2012-03-13 2014-11-27 바이엘 뉴질랜드 리미티드 지속성 조성물
CN103417478B (zh) * 2012-05-18 2014-09-10 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的伊维菌素o/w型注射液及其制备方法
WO2017119928A1 (en) * 2016-01-08 2017-07-13 Abon Pharmaceuticals, Llc Long acting injectable formulations
US20210137960A1 (en) 2018-02-01 2021-05-13 Yale University Compositions and methods for inhibition of nuclear-penetrating antibodies
CN114107097B (zh) * 2021-11-10 2024-03-05 河北兴柏农业科技股份有限公司 一种阿佛曼链霉菌活性孢子的固体发酵工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
DK0393890T3 (da) * 1989-04-11 1992-09-28 Pfizer Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5030650A (en) 1989-09-11 1991-07-09 American Cyanamid Company 13-halo-23-imino derivatives of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
US5055486A (en) 1989-12-22 1991-10-08 American Cyanamid Company 13-alkyl-23-imino derivative of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
DK0525307T3 (da) * 1991-07-23 1996-04-01 American Cyanamid Co Stabile præparater til parenteral indgivelse og deres anvendelse
DK0535734T3 (da) * 1991-09-30 1999-08-09 Merck & Co Inc Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
DE4443888A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Dermal applizierbare Formulierungen von Parasitiziden
EP0873127B1 (en) * 1995-09-25 2006-11-15 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
RU2140737C1 (ru) * 1998-09-22 1999-11-10 Мосин Владимир Александрович Средство для профилактики и лечения паразитарных заболеваний животных
CN1219393A (zh) * 1998-11-13 1999-06-16 王玉万 一种含阿维菌素或伊维菌素的兽用抗寄生虫油剂口服液及其制备方法

Also Published As

Publication number Publication date
US6617314B2 (en) 2003-09-09
DE59708905D1 (de) 2003-01-16
US20020160967A1 (en) 2002-10-31
BR9715298B1 (pt) 2014-10-14
ZA978352B (en) 1998-03-24
WO1998011902A1 (de) 1998-03-26
AU4621597A (en) 1998-04-14
EP0939638B1 (de) 2002-12-04
AU750874B2 (en) 2002-08-01
AR008844A1 (es) 2000-02-23
CN1130203C (zh) 2003-12-10
PL332137A1 (en) 1999-08-30
CA2265952C (en) 2009-11-17
DK0939638T3 (da) 2003-03-24
BRPI9715298B8 (pt) 2016-04-26
ES2184135T3 (es) 2003-04-01
CN1230890A (zh) 1999-10-06
BR9712058A (pt) 1999-08-24
HK1022845A1 (en) 2000-08-25
KR20000035978A (ko) 2000-06-26
JP4822196B2 (ja) 2011-11-24
ATE228845T1 (de) 2002-12-15
CA2265952A1 (en) 1998-03-26
JP2001503029A (ja) 2001-03-06
EP0939638A1 (de) 1999-09-08
DE19638045A1 (de) 1998-03-19
NZ334673A (en) 2000-10-27

Similar Documents

Publication Publication Date Title
BR9712058B1 (pt) formulações para uso de ivermectina, processo para sua preparação e uso.
BR9810116B1 (pt) composição de solução e processo para sua preparação.
BR9708400A (pt) Composição sua preparação e uso
BR9916192B1 (pt) formulações agroquìmicas, processo para a sua preparação e uso das mesmas.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9909995B1 (pt) composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.
BR9804378B1 (pt) compostos, processo para sua produção e uso.
PT934915E (pt) Betao de muito alto desempenho, autonivelante, processo para a preparacao do mesmo e sua utilizacao
BR9815047B1 (pt) composição de aditivo para borracha, processo para sua preparação e sua aplicação.
BR9603429A (pt) Derivado de 11-(fenila substituída) estra-4,9-dieno processo de preparação do mesmo composição farmacêutica e uso deste derivado
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
BR9000116A (pt) Alfa-diazo-beta-cetoester polifuncional,processo para sua preparacao e sua utilizacao
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
BR9600147A (pt) Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
BR9710739B1 (pt) polissacarÍdeos sintÉticos, processo para sua preparaÇço, composiÇÕes farmacÊuticas que os contÊm e utilizaÇço dos mesmos.
BR9713977B1 (pt) composto análogo de comptotecina, e, utilização e processo para preparação do mesmo.
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9600778A (pt) Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento
BR9500671A (pt) Veículos para vernizes,processo para sua preparação e uso
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
BR9600779A (pt) Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento
BR0012329B1 (pt) derivados de benzofurano, processo para sua preparaÇço e uso dos mesmos.
BR9302359A (pt) Composto,processo para sua preparacao,medicamento e uso
BR9505985A (pt) Quitosana n-ciano metilada processo para sua preparação uso e composição cosmética

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/06/2009, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 31/71; A61K 47/10; A61K 47/14; A61K 47/44.

Ipc: A61K 31/7048 (2006.01), A61K 9/00 (2006.01), A61K

Ipc: A61K 31/7048 (2006.01), A61K 9/00 (2006.01), A61K

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 30.06.2019